| Intelligent Polymers Limited | |||
| Ticker: | INP | Clarendon House, 2 Church Street | |
| Exchange: | American Stock Exchange | Hamilton, BERMU HM 11 | |
| Industry: | Manufacturing (SIC Code 2834) | 4412951422 | |
| Type of Shares: | Common Units | Filing Date: | 9/17/97 | |
| U.S. Shares: | 3,250,000 | Offer Date: | 10/9/97 | |
| Non-U.S. Shares: | 0 | Filing Price: | $20.00 | |
| Primary Shares: | 3,250,000 | Offer Price: | $20.00 | |
| Secondary Shares: | 0 | Gross Spread: | $1.40 | |
| Offering Amount: | $65,000,000 | Selling: | $0.84 | |
| Expenses: | - | Reallowance: | $0.10 | |
| Shares Out After: | 3,250,000 | |||
| Spin out parent firm: | Biovail Corporation International | |||
| Manager | Tier | Phone |
| Donaldson, Lufkin & Jenrette Securities Corp. | Lead Manager | (212) 371-0641 |
| Lazard Freres & Co. | Co-manager | (212) 632-6717 |
| SBC Warburg & Company | Co-manager | (212) 224-7274 |
| Issuer's Law Firm: | Cahill Gordon & Reindel |
| Bank's Law Firm: | Shearman & Sterling |
| Auditor: | Deloitte & Touche |
| Business Description |
| The company was formed by Biovail in July 1997, primarily to develop once-daily controlled release versions of selected drugs which are currently marketed only in immediate release form or in controlled release form requiring multiple daily doses. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for working capital and general corporate purposes. |
| Officer Name | Title | Age |
| Eugene N. Melnyk | Chairman/Chief Executive Officer | 38 |
| David J. Doyle | Common Director/Secretary | 43 |
| Robert A. Podruzny | Special Director | 49 |
| # of Units: | 3,250,000 | |||
| Unit Ticker: | INP | Unit Price: | $20.00 | |
| Warrant Ticker: | INP | Warrant Price: | ||
| Warrant Exercise Date: | 10/01/1999 | Warrant Exercise Price: | ||
| Warrant Expiration Date: | ||||
| Warrant Detachable: | Yes | Warrant Detach Date: | 09/30/1999 | |
| Warrant Callable: | No |
| Unit Composition: 1 Common Share of Intelligent Polymers Limited + 1 Biovail Warrant |
| Warrant Entitlement: 1 Common Share of Biovail |